Literature DB >> 24370794

Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease.

Robert H Cleveland1, Catherine Stamoulis, Gregory Sawicki, Emma Kelliher, Evan J Zucker, Christopher Wood, David Zurakowski, Edward Lee.   

Abstract

BACKGROUND: Several imaging-based scoring systems have been used as outcome measures in assessing the severity of cystic fibrosis (CF) lung disease. It has been shown that chest radiography performs equally to computed tomography (CT). There is the opinion that of the two most commonly used chest radiograph (CXR) systems, the Brasfield system is less sensitive and reliable than the Wisconsin system.
OBJECTIVE: This report assesses the reproducibility and reliability of the two systems.
MATERIALS AND METHODS: Thirty patients with CXRs during a 5-year period were randomly selected. One hundred eighty-two studies had data for all CXRs and pulmonary function tests (PFTs), Forced Expiratory Volume in One Second (FEV-1) and Forced Vital Capacity (FVC). PFT values closest to the date of each CXR were recorded. Four radiologists scored each image twice by both the Brasfield and Wisconsin systems. Intra- and inter-rater reliability, correlation with PFTs and direct correlation of the two systems were calculated.
RESULTS: Intra-rater agreement: r = 0.86-0.99 Brasfield, r = 0.78-0.96 Wisconsin. Inter-rater agreement: 0.76-0.90 Brasfield, r = 0.74-0.97 Wisconsin. Brasfield vs. FEV-1: r = 0.55, vs. FVC r = 0.61. Wisconsin vs. FEV-1: r = 0.57, vs. FVC r = 0.66. Correlation of the two systems: r = 0.86 (all P < 0.001).
CONCLUSION: The Brasfield and Wisconsin systems performed very similarly providing equally reproducible, robust and reliable measures.

Entities:  

Mesh:

Year:  2013        PMID: 24370794     DOI: 10.1007/s00247-013-2848-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  18 in total

1.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

2.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

3.  The relationship between tests of lung function and three chest radiological scoring systems in patients with cystic fibrosis.

Authors:  E B Wong; J Regnis; R C Shnier; P T Bye; M E Stewart
Journal:  Australas Radiol       Date:  1993-08

4.  Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study.

Authors:  D Brasfield; G Hicks; S Soong; J Peters; R Tiller
Journal:  AJR Am J Roentgenol       Date:  1980-06       Impact factor: 3.959

5.  Cystic fibrosis: a system for assessing and predicting progression.

Authors:  R H Cleveland; A S Neish; D Zurakowski; D P Nichols; M E Wohl; A A Colin
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

6.  Cystic fibrosis genotype and assessing rates of decline in pulmonary status.

Authors:  Robert H Cleveland; David Zurakowski; Dubhfeasa Slattery; Andrew A Colin
Journal:  Radiology       Date:  2009-12       Impact factor: 11.105

7.  Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patients.

Authors:  R H Cleveland; A S Neish; D Zurakowski; D P Nichols; M E Wohl; A A Colin
Journal:  AJR Am J Roentgenol       Date:  1998-11       Impact factor: 3.959

8.  Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system.

Authors:  I Nathanson; K Conboy; S Murphy; E Afshani; J P Kuhn
Journal:  Pediatr Pulmonol       Date:  1991

9.  CF: an X-ray database to assess effect of aerosolized tobramycin.

Authors:  Dubhfeasa M Slattery; David Zurakowski; Andrew A Colin; Robert H Cleveland
Journal:  Pediatr Pulmonol       Date:  2004-07

10.  High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.

Authors:  Alan S Brody; Jeffrey S Klein; Paul L Molina; Joanne Quan; Judy A Bean; Robert W Wilmott
Journal:  J Pediatr       Date:  2004-07       Impact factor: 4.406

View more
  5 in total

Review 1.  Ten years of chest MRI for patients with cystic fibrosis : Translation from the bench to clinical routine.

Authors:  Patricia Leutz-Schmidt; Monika Eichinger; Mirjam Stahl; Olaf Sommerburg; Jürgen Biederer; Hans-Ulrich Kauczor; Michael U Puderbach; Marcus A Mall; Mark O Wielpütz
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

2.  Similar performance of Brasfield and Wisconsin scoring systems in young children with cystic fibrosis.

Authors:  Robert H Cleveland; Gregory S Sawicki; Catherine Stamoulis
Journal:  Pediatr Radiol       Date:  2015-05-29

Review 3.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

4.  Multidimensional clinical phenotyping of an adult cystic fibrosis patient population.

Authors:  Douglas J Conrad; Barbara A Bailey
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  A chest radiograph scoring system in patients with severe acute respiratory infection: a validation study.

Authors:  Emma Taylor; Kathryn Haven; Peter Reed; Ange Bissielo; Dave Harvey; Colin McArthur; Cameron Bringans; Simone Freundlich; R Joan H Ingram; David Perry; Francessa Wilson; David Milne; Lucy Modahl; Q Sue Huang; Diane Gross; Marc-Alain Widdowson; Cameron C Grant
Journal:  BMC Med Imaging       Date:  2015-12-29       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.